Global and China Risperidone Market Size 2019 - 2020 Forecast Reports

Nov 11, 2015, 07:30 ET from RnR Market Research

PUNE, Maharashtra, November 11, 2015 /PRNewswire/ --

Investigation Report on China Risperidone Market, 2010-2019 and Global Risperidone Industry Report 2015 are new Chinese and global studies now available in the mental illness drugs intelligence collection of

Complete report on Chinese risperidone market spread across 40 pages, covering information on 6 companies and supported with 25 charts is now available at .

According to a market survey, the annual sales of risperidone increased from CNY 38 million in 2005 to CNY 103 million in 2014. And Xian Janssen Pharmaceutical Ltd. had the largest market share of about 48% for sales value in 2014. China now faces a series of complex and urgent medical demand. With lifestyle changes and pressure brought about by economic development, the number of people suffering from mental disorder goes up to over 100 million in China, which boosts the demand for antipsychotic. Meanwhile, with ageing population, dementia patients grow in number, increasing the demand for drugs that can ameliorate psychological symptoms.

The market size of risperidone is expected to keep growing in the next few years in China. Companies mentioned in this research are Xian Janssen Pharmaceutical Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd, Jilin Province Xidian Pharmaceutical SciTech Development Co., Ltd, Shandong Qilu Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceutical Co., Ltd and Jiangsu Nhwa Pharmaceutical Co., Ltd. Order a copy of Investigation Report on China Risperidone Market, 2010-2019 at .

Similar research titled Global Risperidone Industry Report 2015 is a professional and in-depth study on the current state of the Risperidone industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Risperidone market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Risperidone industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 168 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies included in this research are Risperidone industry such as, TEVA, MYLAN, APOTEX, SUN PHARMA, Zydus, SANDOZ and ENDO. Browse complete Global Risperidone Industry Report 2015 at .

Explore more Mental Illness Drugs market reports at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441

Connect with Us: 
G+ / Google Plus:
RSS / Feeds:

SOURCE RnR Market Research